SEREBRAL İSKEMİ/REPERFÜZYONA BAĞLI OKSİDAN BEYİN HASARINA KARŞI MELATONİN VE AMLODİPİNİN KORUYUCU ETKİLERİ

Year 2009, Volume: 22 Issue: 1, 34 - 44, 04.05.2015

Hale Toklu Mustafa Deniz Meral Yüksel Meral Keyer-uysal Göksel Şener

Abstract

Amaç: Bu çalışmada melatonin ve amlodipinin iskemi/reperfüzyon (İ/R) ile oluşan beyin hasarına karşı olası koruyucu etkileri araştırıldı. Yöntem: Wistar Albino sıçanlar 15 dakika bilateral carotid arter oklüzyonunu takiben 24 saat süreyle reperfüzyona bırakıldı. Melatonin ve amlodipin 10mg/kg ip veya 50µg/sıçan icv dozlarında reperfüzyondan hemen önce uygulandı. Nörolojik tayin sonrası hayvanlar dekapite edildi. Beyin dokularında malondialdehit (MDA) ve glutatyon (GSH) düzeyleri ile myeloperoxidaz (MPO) ve Na+-K+-ATPaz aktiviteleri tayin edildi. Dokuda serbest radikal oluşumu luminol ve lusigenin kemiluminesans (KL) yöntemi ile ölçüldü. Beyin ödemi yaş/kuru ağırlık üzerinden, kan beyin bariyer (KBB) geçirgenliği de Evans Mavisi (EM) extravazasyonu ile değerlendirilidi. Bulgular: Çözücü uygulanan grup ile karşılaştırıldığında nörolojik bozuklukların melatonin ve amlodipin gruplarında düzeldiği belirlendi. İskemi/reperfüzyon beyinde GSH ve Na+-K+-ATPaz aktivitesinde azalma ve bununla birlikte MDA, MPO ve KL düzeylerinde artışa neden oldu. Buna karşılık melatonin ve amlodipin tedavileri tüm incelenen biyokimyasal parametrelerdeki değişimi ve İ/R nin neden olduğu beyin ödemini geri çevirdi. Sonuç: Bu bulgulara göre gerek melatonin ve gerekse amlodipin muhtemelen antioksidan özellikleri aracılığı ile global iskemiye bağlı olarak meydana gelen nörokimyasal ve davranışsal değişikleri module edebileceği düşünülmektedir.

Anahtar Kelimeler: melatonin, amlodipin, beyin, iskemi / reperfüzyon, lipid peroksidasyonu

Keywords

melatonin, amlodipin, beyin, iskemi / reperfüzyon, lipid peroksidasyonu

References

• 1. Matsuo Y, Onodera H, Shiga Y, et al. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res 1994;656:344-352.
• 2. Tan DX, Manchester LC, Reiter RJ, et al. Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 2000;9:137-159.
• 3. Chauvin G, Vannier G, Gilad E, et al. Melatonin is a scavenger of peroxynitrite. Life Sci 1997;60:169-174.
• 4. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007;42:28-42.
• 5. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007;42:386-393.
• 6. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochem Biophys 2001;34:237-256.
• 7. Yoshii T, Iwai M, Li Z, et al. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 2006;29:457-466.
• 8. Liu LL, Li QX, Xia L, Li J, Shao L. Differential effects of dihydropyridine calcium antagonists on doxorubicininduced nephrotoxicity in rats. Toxicology 2007;231:81- 90.
• 9. Yamagata K, Ichinose S, Tagami M. Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Hypertens Res 2004;27:271-282.
• 10. Hirooka Y, Kimura Y, Nozoe M, et al. Amlodipineinduced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in strokeprone spontaneously hypertensive rats. Hypertens Res 2006;29:49-56.
• 11. Mogi M, Iwai M, Chen R, et al. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice. Am J Hypertens 2006;19:1144-1149.
• 12. Toklu HZ, Keyer Uysal M, Kabasakal L, et al. The effects of riluzole on neurological, biochemical and histological changes in early and late term of sepsis in rats. J Surg Res 2008; Doi:10.1016/j.jss.2008.03.013.
• 13. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurological examination. Stroke 1986;17:472-476.
• 14. Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302–311.
• 15. Beutler E. Glutathione in red blood cell metabolism. A Manuel of Biochemical Methods, Grune and Stratton, New York, NY: 1975:112–114.
• 16. Hillegass LM, Griswold DE, Brickson B, AlbrightsonWinslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990; 24: 285- 295.
• 17. Reading HW, Isbir T. The role of cation activated ATPase in transmitter release from the art iris. Q J Exp Physiol Cogn Med Sci 1980;65:105-116.
• 18. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-75.
• 19. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;92:2546-2551.
• 20. Davies GR, Simmonds NJ, Stevens TR, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179–185.
• 21. Read JS, Hirano T, Davis SM, Donnan GA. Limiting neurological damage after stroke. Drugs Aging 1999;14:11–39.
• 22. Candelario-Jalil E, Alvarez D, Merino N, León OS. Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils. Neurosci Res 2003;47:245-253.
• 23. Ozkul A, Akyol A, Yenisey C, et al. Oxidative stress in acute ischemic stroke. J Clin Neurosci 2007;14:1062- 1066.
• 24. Ross D. Glutathione, free radicals and chemotherapeutic agents. Pharmacol Ther 1988;37:231-249.
• 25. Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacol 2001;40:959-975.
• 26. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004;134:489-492.
• 27. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD. Macrophages and neurodegeneration. Brain Res Rev 2005;48:185-195.
• 28. Homi HM, Freitas JJ, Curi R, Velasco IT, Junior BA. Changes in superoxide dismutase and catalase activities of rat brain regions during early global transient ischemia/reperfusion. Neurosci Lett 2002;333:37-40.
• 29. Kim GW, Kondo T, Noshita N, Chan PH. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke 2002;33:809-815.
• 30. Koner BC, Banerjee BD, Ray A. Organochlorine pesticide-induced oxidative stress and immune suppression in rats. Ind J Exp Biol 1998;36:395-398.
• 31. Tuna M, Polat S, Erman T, et al. Effect of anti-rat interleukin-6 antibody after spinal cord injury in the rat: inducible nitric oxide synthase expression, sodium- and potassium-activated, magnesium-dependent adenosine- 5\'-triphosphatase and superoxide dismutase activation, and ultrastructural changes. J Neurosurg 2001;95:64-73.
• 32. Mrsic-Pelcic J, Pelcic G, Vitezic D, et al. Hyperbaric oxygen treatment: the influence on the hippocampal superoxide dismutase and Na+,K+-ATPase activities in global cerebral ischemia-exposed rats. Neurochem Int 2004;44:585-594.
• 33. Kempski O. Cerebral edema. Semin Nephrol 2001; 21: 303-307.
• 34. Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience 2004;129:1021-1029.
• 35. Kaptanoglu E, Okutan O, Akbiyik F, et al. Correlation of injury severity and tissue Evans blue content, lipid peroxidation and clinical evaluation in acute spinal cord injury in rats. J Clin Neurosci 2004;11:879-885.
• 36. Mason RP, Walter MF, Trumbore MW, Olmstead Jr. EG, Mason PE. Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J Mol Cell Cardiol 1999;31:275–281.
• 37. Uchida S, Yamada S, Nagai K, Deguchi Y, Kimura R. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists. Life Sci 1997;61:2083-2090.
• 38. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998;56:359–384.